Navigation Links
Smith & Nephew introduces powerful new e-learning platform

LONDON, Nov. 21, 2013 /PRNewswire/ -- Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, today unveils Education and Evidence, a new e-learning platform for surgeons to access and share peer-to-peer educational resources. Supporting joint repair and replacement, extremities, and trauma specialties, the member-based service at already hosts more than 1,000 videos, articles, surgical techniques, podcasts, training courses, tablet PC apps and iBooks™.

The launch coincides with the opening day of Global Insights: The Future of Hip and Knee Surgery, Smith & Nephew's medical education event in Copenhagen, Denmark, attended by more than 450 orthopaedic surgeons from 33 different countries.

"Smith & Nephew has been supporting healthcare professionals for over 150 years," says Michael Frazzette, President of Smith & Nephew's Advanced Surgical Devices division. "Today we proudly continue this tradition by giving our customers digital access to trusted, peer-to-peer educational resources at the most convenient time and on their device of choice."

Education and Evidence uses an innovative search engine and self-profiling to tailor content to users, while also enabling the sharing of resources with colleagues. It includes links to the first two in a series of surgical technique guides, which are available through the iBooks StoreSM for use on the Mac® and iPad® platforms. And the site also hosts a new iPad and Android(TM) app on ligament balancing, which features 22 videos and more than 60 screens of content.  

"I find this level of commitment and creativity among our industry partners to be invaluable," says Prof Carsten Perka, MD, of Berlin, Germany, who is a chairperson at this week's Global Insights conference. "Smith & Nephew sets the new standard today. Learning from my peers and sharing knowledge across these platforms will help me bring new ideas, new ways of working and treating patients, into my clinical practice. And as I publish my work on the website, others can learn from me."

Course details, faculty information and chairperson interviews for Global Insights: The Future of Hip and Knee Surgery, can be found at

About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith & Nephew has around 11,000 employees and a presence in more than 90 countries. Annual sales in 2012 were more than $4.1 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).

Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in integrating acquired businesses, and disruption that may result from changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors.

Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.  

Trademark of Smith & Nephew.  Certain marks registered US Patent and Trademark Office. All Trademarks Acknowledged.

Apple and iBooks are Trademarks of Apple, Inc.  iBooks Store is a Service mark of Apple, Inc.

Android is a trademark of Google Inc.


SOURCE Smith & Nephew
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith To Present New Research On USL255 (Extended-Release Topiramate) At 2013 American Epilepsy Society Annual Meeting
2. WPPS GO Team Awarded Tums and Eno Global Account by GlaxoSmithKline
3. Smith & Nephew Introduces Advanced Biocomposite Material for Use in Arthroscopic Surgery
4. Upsher-Smith To Present Findings From Global Phase 3 Trial Investigating USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures At 2013 American Epilepsy Society Meeting
5. Grant from Smith & Nephew Helps Continue Educational Activities for Podiatric Surgeons
6. Smith Brothers Cough Drops Wants To Rename Boston "Beardston"
7. GlaxoSmithKline CFO Interviewed on Q3 results
8. The Smith Brothers Co. Selects DEACOM ERP to Strengthen QC and Facilitate Growth
9. Upsher-Smith Announces Development Agreement With Lundbeck
10. H. D. Smith Completes Full Ownership Acquisition Of Triplefin, Solidifying End-To-End Value Chain For Pharmaceutical And Patient Support Services
11. Healthpoint Biotherapeutics To Assume Smith & Nephew Name
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015 During ... in San Francisco, CA , ... to the coronary marketplace. During a satellite symposium, ... Stent Design to Minimize Restenosis", a renowned physician ... available Medinol NIRxcell™ CoCr Coronary Stent System and ...
(Date:12/1/2015)... DUBLIN , Dec. 01, 2015 ... addition of the "Veterinary Equipment and Disposables ... to 2020" report to their offering. ... of the "Veterinary Equipment and Disposables Market ... 2020" report to their offering. --> ...
(Date:12/1/2015)... , Dec. 1, 2015   MabVax Therapeutics Holdings, ... company, announces it has filed an Investigational New Drug ... (FDA) for the Company,s lead fully human antibody product ... acceptance, MabVax plans to initiate the Phase I clinical ... --> The planned Phase I trial ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 01, 2015 , ... Integrated Rental Services (“Integrated Rental”), a ... LLC (“JII”). , With support from JII, Integrated Rental is poised for expansion ... centers, clinics, research labs and medical facilities across the United States. , General ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , ... that its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging ... also announced that it has been selected as a 2015 U.S.A. Taste Champion in ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... the 1980s we have seen vast improvements in scientific research and discoveries, leading ... strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... that it has been selected as a finalist in this year’s Fierce Innovation ... FierceMobileHealthcare. Next IT Healthcare was recognized as a finalist in the category of ...
Breaking Medicine News(10 mins):